139 related articles for article (PubMed ID: 2285979)
21. Novel renin inhibitors containing (2S,3S,5S)-2-amino-1-cyclohexyl-6-methyl-3,5-heptanediol fragment as a transition-state mimic at the P1-P1' cleavage site.
Yamada Y; Ando K; Ikemoto Y; Tada H; Shirakawa E; Inagaki E; Shibata S; Nakamura I; Hayashi Y; Ikegami K; Uchida I
Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1631-41. PubMed ID: 9353891
[TBL] [Abstract][Full Text] [Related]
22. Novel renin inhibitors containing derivatives of N-alkylleucyl-β-hydroxy-γ-amino acids.
Winiecka I; Jaworski P; Mazurek AP; Marszałek D; Goldnik A; Sokulski D
J Pept Sci; 2016 Feb; 22(2):106-15. PubMed ID: 26780837
[TBL] [Abstract][Full Text] [Related]
23. alpha-Hydroxy phosphinyl-based inhibitors of human renin.
Patel DV; Rielly-Gauvin K; Ryono DE; Free CA; Rogers WL; Smith SA; DeForrest JM; Oehl RS; Petrillo EW
J Med Chem; 1995 Oct; 38(22):4557-69. PubMed ID: 7473584
[TBL] [Abstract][Full Text] [Related]
24. Novel renin inhibitors containing a non-peptide aminoalkanoyl moiety at P1-P1' position.
Winiecka I; Marszałek D; Goldnik A; Jaworski P; Mazurek AP
Pharmazie; 2014 Apr; 69(4):263-70. PubMed ID: 24791589
[TBL] [Abstract][Full Text] [Related]
25. Substrate specificity and inhibitor structure-activity relationships of recombinant human renin: implications in the in vivo evaluation of renin inhibitors.
Evans DB; Cornette JC; Sawyer TK; Staples DJ; de Vaux AE; Sharma SK
Biotechnol Appl Biochem; 1990 Apr; 12(2):161-75. PubMed ID: 2184838
[TBL] [Abstract][Full Text] [Related]
26. Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogues of angiotensinogen.
Sham HL; Bolis G; Stein HH; Fesik SW; Marcotte PA; Plattner JJ; Rempel CA; Greer J
J Med Chem; 1988 Feb; 31(2):284-95. PubMed ID: 3276890
[TBL] [Abstract][Full Text] [Related]
27. New renin inhibitors containing pseudodipeptidic units in P3-P2 and P1-P1' positions.
Paruszewski R; Jaworski P; Bodnar M; Dudkiewicz-Wilczyńska J; Roman I
Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1305-9. PubMed ID: 16204988
[TBL] [Abstract][Full Text] [Related]
28. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
Raddatz P; Jonczyk A; Minck KO; Rippmann F; Schittenhelm C; Schmitges CJ
J Med Chem; 1992 Sep; 35(19):3525-36. PubMed ID: 1404233
[TBL] [Abstract][Full Text] [Related]
29. New renin inhibitors containing novel analogues of statine.
Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
[TBL] [Abstract][Full Text] [Related]
30. Renin inhibitor SC-51106 complexed with human renin: discovery of a new binding site adjacent to P3.
Hanson GJ; Clare M; Summers NL; Lim LW; Neidhart DJ; Shieh HS; Stevens AM
Bioorg Med Chem; 1994 Sep; 2(9):909-18. PubMed ID: 7712126
[TBL] [Abstract][Full Text] [Related]
31. Effects of glycosylation of the residue at position 14 in ovine angiotensinogen on the human renin reaction.
Inui Y; Orihashi T; Nakagawa T; Ebihara A; Suzuki F; Nakamura Y
Biosci Biotechnol Biochem; 1998 Aug; 62(8):1612-4. PubMed ID: 9757569
[TBL] [Abstract][Full Text] [Related]
32. Renin inhibitors based on novel dipeptide analogues. Incorporation of the dehydrohydroxyethylene isostere at the scissile bond.
Kempf DJ; de Lara E; Stein HH; Cohen J; Plattner JJ
J Med Chem; 1987 Nov; 30(11):1978-83. PubMed ID: 3312604
[TBL] [Abstract][Full Text] [Related]
33. The amino-acid residues on the C-terminal side of the cleavage site of angiotensinogen influence the species specificity of reaction with renin.
Burton J; Quinn T
Biochim Biophys Acta; 1988 Jan; 952(1):8-12. PubMed ID: 3275468
[TBL] [Abstract][Full Text] [Related]
34. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
Williams PD; Perlow DS; Payne LS; Holloway MK; Siegl PK; Schorn TW; Lynch RJ; Doyle JJ; Strouse JF; Vlasuk GP
J Med Chem; 1991 Mar; 34(3):887-900. PubMed ID: 2002469
[TBL] [Abstract][Full Text] [Related]
35. Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions.
Paschalidou K; Neumann U; Gerhartz B; Tzougraki C
Biochem J; 2004 Sep; 382(Pt 3):1031-8. PubMed ID: 15233625
[TBL] [Abstract][Full Text] [Related]
36. Exploiting the molecular template of angiotensinogen in the discovery and design of peptidyl, pseudopeptidyl and peptidimimetic inhibitors of human renin: a structure-activity perspective.
Sawyer TK; Hester JB; Schostarez HJ; Thaisrivongs S; Bundy GL; Liu L; Bradford VS; De Vaux AE; Staples DJ; Maggiora LL
Adv Exp Med Biol; 1991; 306():307-23. PubMed ID: 1812721
[No Abstract] [Full Text] [Related]
37. Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides.
Hui KY; Carlson WD; Bernatowicz MS; Haber E
J Med Chem; 1987 Aug; 30(8):1287-95. PubMed ID: 3302256
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of renin inhibitors: incorporation of transition-state isostere side chains that span from the S1 to the S3 binding pockets and examination of P3-modified renin inhibitors.
Plummer MS; Shahripour A; Kaltenbronn JS; Lunney EA; Steinbaugh BA; Hamby JM; Hamilton HW; Sawyer TK; Humblet C; Doherty AM
J Med Chem; 1995 Jul; 38(15):2893-905. PubMed ID: 7636850
[TBL] [Abstract][Full Text] [Related]
39. Highly potent and specific inhibitors of human renin.
Sham HL; Stein H; Rempel CA; Cohen J; Plattner JJ
FEBS Lett; 1987 Aug; 220(2):299-301. PubMed ID: 3111889
[TBL] [Abstract][Full Text] [Related]
40. Renin inhibitory peptides: a study of structural modifications in the peptide backbone.
Thaisrivongs S; Pals DT; Turner SR; Kroll LT
J Hypertens Suppl; 1989 Apr; 7(2):S21-3. PubMed ID: 2666608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
